View Cart (0 items)

Pharmaceutical

DSM announces South American biologics manufacturing contract

PARSIPPANY, N.J. — DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM N.V. announced a biologics contract manufacturing agreement with its first Brazilian client, RECEPTA Biopharma
Read More

Global spending on medicines to reach nearly $1.2 trillion by 2016

PARSIPPANY, N.J. — Following several years of slowing growth, the global market for medicines is poised to rebound from an expected low point of 3% - 4% growth in
Read More

Par Pharmaceutical Companies to be acquired by TPG

WOODCLIFF LAKE, N.J. — Par Pharmaceutical Companies has entered into a definitive merger agreement to be acquired by an affiliate of TPG in a transaction with an equity value
Read More

Bristol-Myers Squibb to acquire Amylin

NEW YORK Normal.dotm 0 0 1 1 Grand View Media Group 1 1 1 12.0 0 false 18 pt 18 pt 0 0 false false false /* Style Definitions
Read More

Extractables Testing for Silicone & TPE Tubing Products

AdvantaPure now offers one of the most comprehensive portfolios of extractables testing for silicone and TPE (thermoplastic elastomer) tubing in the pharmaceutical and clean application industries. The company conducted
Read More

Codexis wins Presidential Green Chemistry Challenge Award

REDWOOD CITY, Calif. — Codexis, Inc., a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceutical intermediates, received the annual Presidential Green Chemistry Challenge Award from
Read More

Philip Blake to head Bayer’s US operations

PITTSBURGH and WAYNE, N.J. — German-based Bayer AG announced Tuesday that Philip Blake has been named Senior Bayer Representative (SBR) USA. The appointment is effective July 1. Blake succeeds Greg
Read More

Pfizer to cut workforce in response to slowing demand for Lipitor

CORK, Ireland — Pfizer announced it is eliminating 177 jobs at its plants in Ireland in response to a fall in demand for anti-cholesterol drug Lipitor, The Irish Times
Read More

Study details foreign efforts to lure biopharmaceutical companies

Despite increasing budget pressures, countries around the world are making substantial investments in pro-innovation policies and programs to lure the biopharmaceutical research sector away from the U.S., finds a
Read More

US may speed approval of ''breakthrough'' drugs

WASHINGTON — Reuters reports, experimental drugs that show a big effect early in development for treating serious or life-threatening diseases would get a faster and cheaper path to U.S. approval,
Read More